InsiderTrades

Form 4 for MGNX MACROGENICS INC

Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-15 · accession 0001125345-25-000036 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-19 2025-02-15 MGNX Karrels James SVP, CFO, Sec F - Tax $2.56 -5,790 186.8K -3% -$14.8K
D 2025-02-19 2025-02-15 MGNX Karrels James SVP, CFO, Sec M - OptEx $0.00 +15.0K 192.6K +8% $0
D 2025-02-19 2025-02-15 MGNX Karrels James SVP, CFO, Sec M - OptEx $0.00 -15.0K 15.0K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-15 F D 5,790 $2.56 186,801 D — — (F2) Owned jointly with reporting person's wife.
2 Common Common Stock 2025-02-15 M A 14,998 $0.00 192,591 D — — (F1) On February 15, 2023, the reporting person was granted 45,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. (F2) Owned jointly with reporting person's wife.
3 Derivative Restricted Stock Unit 2025-02-15 M D 14,998 $0.00 14,999 D $0.00 · — to — 14,998 Common Stock (F1) On February 15, 2023, the reporting person was granted 45,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.